HSE pays 47% more for 'brand name' drugs

A new survey has found that Ireland's Health Service is paying one-and-a-half times more than Britain for brand name medicines.

The study carried out for the Swedish pharmaceutical sector shows that Ireland pays more than any other Northern European country for drugs that are still under patent.

The survey found that the HSE pays 47% more than Britain's NHS for such "brand name" drugs.

More in this Section

Heat on TDs as President Higgins rejects pay rise

'Equal pay for equal work' redline issue for ASTI secondary teachers

Shift workers more likely to have bad habits such as skipping meals and smoking

Only 30% of Irish people have a will

Today's Stories

Anthony Foley: Thomond stands up and fights for Axel

Cobh Ramblers liaising with gardaí after fans clash

Decision pending on lung drug

Enda Kenny is top TD for contact with Revenue


Books explores children's reaction to widowed father's wish to remarry

Getting up close to Ireland's scariest psychopaths

Pixie Geldof is singing through the pain of losing her sister, Peaches

Scandinavian interiors’ shop takes over former Mothercare premises on Patrick's Street

More From The Irish Examiner